AndreaHarzstarkMD
Oncology • San Francisco, CAAssistant Professor, Medicine, University of California, San Francisco, School of Medicine
Are you Dr. Harzstark?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 71 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1600 Divisadero St
Urologic Oncology 3RD floor Box 1711
San Francisco, CA 94143Phone+1 415-353-7171
Summary
- Dr. Andrea Harzstark, MD is an oncologist in San Francisco, California. She is currently licensed to practice medicine in California. She is affiliated with UCSF Medical Center and Kaiser Permanente Oakland Medical Center.
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2005 - 2008
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2002 - 2005
Stanford University School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2004 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy Start of enrollment: 2006 Apr 01
- Everolimus/Sorafenib or Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC) Start of enrollment: 2012 Jul 01
Publications & Presentations
PubMed
- 337 citationsCabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation TrialDavid Smith, Matthew R. Smith, Christopher Sweeney, Aymen Elfiky, Christopher J. Logothetis
Journal of Clinical Oncology. 2013-02-01 - 42 citationsPhase II results of Dovitinib (TKI258) in patients with metastatic renal cell cancer.Bernard Escudier, Viktor Grünwald, Alain Ravaud, Yen-Chuan Ou, Daniel Castellano
Clinical Cancer Research. 2014-06-01 - 922 citationsMetabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1-13C]PyruvateSarah J. Nelson, John Kurhanewicz, Daniel B. Vigneron, Peder E. Z. Larson, Andrea L. Harzstark
Science Translational Medicine. 2013-08-14
Press Mentions
With Help from Kaiser Permanente, Bladder Cancer CuredJune 28th, 2017
